Immunotherapy is a crucial aspect in cancer treatment, enabling the body’s immune system to fight tumors. A recent study found that removing specific enzymes regulating epigenetic processes in dendritic cells can enhance anti-tumor immunity. This discovery may lead to new strategies in immunotherapy. Cancer cells are challenging to combat because the immune system struggles to recognize them. Dendritic cells play a key role in immune response development, with the enzyme HDAC1 found to be essential in their development and function. By targeting this enzyme, researchers were able to improve the immune response against tumors. The study provides valuable insights for further advancements in cancer immunotherapy.
Source link
Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy
